April 28, 2023
January 25, 2025
This week’s newsletter included:
-
ATL Technology Acquires Gyrus Medical
-
Ivy Estabrooke Named to US Air Force Roundtable
-
Oxford Nanopore and bioMérieux to Enter Into a Strategic Partnership Agreement
-
bioMérieux Releases Q1 Financial Results
-
BioFire Defense Partners With BARDA on Specific Diagnostics Rapid AST System
-
BD Recognized by Forbes as a Best Employer for Diversity in 2023 List
-
BD Board Declares Dividend
-
Bridge Features Utah Biotech
-
Teiko Bio CEO, Ramji Srinivasan Highlighted in Podcast and Article
-
Utah State University President, Noelle Cockett, Visits SEEK Labs
-
Gov. Cox Recognizes Undiagnosed Rare Disease Day
-
Governor-Led Trade Mission to France and U.K.
-
Opportunity for Early-Stage Founders to Apply for the University of Utah’s Master of Business Creation Program
Featured New Member: Innovabio
Recent News
- BioSeeker™ Powers Development of a First-of-Its-Kind Programmable Therapeutic for Respiratory Syncytial Virus (RSV)
- Canary Speech Achieves HITRUST e1 Certification for Voice Biomarker Platform
- Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral ENPP1 Inhibitor for Hypophosphatasia
- Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
- GE HealthCare’s Economic Impact Across Utah
- RefloDx Wins Trans Atlantic Angel Grand Prize